These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mice Survival and Plasmatic Cytokine Secretion in a "Two Hit" Model of Sepsis Depend on Intratracheal Pseudomonas Aeruginosa Bacterial Load. Restagno D; Venet F; Paquet C; Freyburger L; Allaouchiche B; Monneret G; Bonnet JM; Louzier V PLoS One; 2016; 11(8):e0162109. PubMed ID: 27574993 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218 [TBL] [Abstract][Full Text] [Related]
7. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686 [TBL] [Abstract][Full Text] [Related]
8. Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Vyas D; Javadi P; Dipasco PJ; Buchman TG; Hotchkiss RS; Coopersmith CM Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R1048-53. PubMed ID: 15947070 [TBL] [Abstract][Full Text] [Related]
9. Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Parra-Millán R; Jiménez-Mejías ME; Ayerbe-Algaba R; Domínguez-Herrera J; Díaz C; Pérez Del Palacio J; Pachón J; Smani Y Enferm Infecc Microbiol Clin (Engl Ed); 2022 Jan; 40(1):14-21. PubMed ID: 34991848 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression. Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003 [TBL] [Abstract][Full Text] [Related]
11. Chronic Alcohol Ingestion Worsens Survival and Alters Gut Epithelial Apoptosis and CD8+ T Cell Function After Pseudomonas Aeruginosa Pneumonia-Induced Sepsis. Klingensmith NJ; Fay KT; Lyons JD; Chen CW; Otani S; Liang Z; Chihade DB; Burd EM; Ford ML; Coopersmith CM Shock; 2019 Apr; 51(4):453-463. PubMed ID: 29664837 [TBL] [Abstract][Full Text] [Related]
12. IL-27 controls sepsis-induced impairment of lung antibacterial host defence. Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706 [TBL] [Abstract][Full Text] [Related]
13. [Protective effects of recombinant trichinella spiralis-53 000 protein combining with imipenem on polymicrobial septic mice]. Li F; Chen Z; Tang H; Liang Y; Li Z; Wu J; Zeng L; Yang W; Hu X; Ma Z Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):433-8. PubMed ID: 29920040 [TBL] [Abstract][Full Text] [Related]
14. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412 [TBL] [Abstract][Full Text] [Related]
15. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Pallua N; Low JF; von Heimburg D Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624 [TBL] [Abstract][Full Text] [Related]
16. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. Osuchowski MF; Welch K; Siddiqui J; Remick DG J Immunol; 2006 Aug; 177(3):1967-74. PubMed ID: 16849510 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of caffeoylxanthiazonoside isolated from fruits of Xanthium strumarium on sepsis mice. Wang YH; Li TH; Wu BQ; Liu H; Shi YF; Feng DY Pharm Biol; 2015; 53(9):1367-71. PubMed ID: 25868616 [TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]